158 related articles for article (PubMed ID: 1970752)
1. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts.
Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S
Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752
[TBL] [Abstract][Full Text] [Related]
2. Effect of a dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo- 1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3 -pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin.
Niwa K; Yamada K; Furukawa T; Shudo N; Seto K; Matsumoto T; Takao S; Akiyama S; Shimazu H
Cancer Res; 1992 Jul; 52(13):3655-60. PubMed ID: 1617639
[TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
Sumizawa T; Chen ZS; Chuman Y; Seto K; Furukawa T; Haraguchi M; Tani A; Shudo N; Akiyama SI
Mol Pharmacol; 1997 Mar; 51(3):399-405. PubMed ID: 9058594
[TBL] [Abstract][Full Text] [Related]
4. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
6. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
7. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI
Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571
[TBL] [Abstract][Full Text] [Related]
8. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
[TBL] [Abstract][Full Text] [Related]
9. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors.
Zhou XF; Zhang L; Tseng E; Scott-Ramsay E; Schentag JJ; Coburn RA; Morris ME
Drug Metab Dispos; 2005 Mar; 33(3):321-8. PubMed ID: 15585608
[TBL] [Abstract][Full Text] [Related]
10. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
11. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
[TBL] [Abstract][Full Text] [Related]
12. Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotype.
Tolomeo M; Gancitano RA; Musso M; Porretto F; Perricone R; Abbadessa V; Cajozzo A
Haematologica; 1994; 79(4):328-33. PubMed ID: 7806087
[TBL] [Abstract][Full Text] [Related]
13. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
14. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
Vanhoefer U; Cao S; Minderman H; Tóth K; Scheper RJ; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Feb; 2(2):369-77. PubMed ID: 9816180
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl 5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate dihydrochloride (NIP-101).
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2370-6. PubMed ID: 1446357
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance by two novel indole derivatives.
Kadam S; Maus M; Poddig J; Schmidt S; Rasmussen R; Novosad E; Plattner J; McAlpine J
Cancer Res; 1992 Sep; 52(17):4735-40. PubMed ID: 1355008
[TBL] [Abstract][Full Text] [Related]
17. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.
Höllt V; Kouba M; Dietel M; Vogt G
Biochem Pharmacol; 1992 Jun; 43(12):2601-8. PubMed ID: 1352973
[TBL] [Abstract][Full Text] [Related]
18. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
[TBL] [Abstract][Full Text] [Related]
19. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.
Coon JS; Knudson W; Clodfelter K; Lu B; Weinstein RS
Cancer Res; 1991 Feb; 51(3):897-902. PubMed ID: 1988130
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]